This focused after-action review (AAR), conducted by ECDC in collaboration with the Finnish Institute for Health and Welfare (THL), investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron...

At the request of the Slovenian National Institute of Public Health (NIJZ), ECDC designed and facilitated an After- Action review (AAR) for the NIJZ, focusing on the response to the COVID-19 pandemic between October 2020 to March 2021. ECDC managed the methodological approach and were the...

This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living...

Following a request from the US Centers for Disease Control and Prevention (US CDC) and the World Health Organization Regional Office for Europe, the European Centre for Disease Prevention and Control (ECDC) made its first major contribution to outbreak response activities in the field in...

In 2015, ECDC commissioned an evaluation of the ECDC guidance HIV testing: increasing uptake and effectiveness in the European Union published in December 2010. The aim of the evaluation was to review the impact of the ECDC 2010 guidance and to assess the current need for ECDC HIV testing...

The aim of the literature review presented in this report was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 'Guidance on the prevention and control of infectious diseases among people who inject drugs'. The evidence presented here focuses on the...

This report presents the results of two literature reviews. The aim of the reviews was to provide evidence to inform the recommendations made by ECDC and the EMCDDA in the 2011 publication 'Guidance on the prevention and control of infectious diseases among people who inject drugs'. The evidence...

During the past decade, the 53 Member States of the WHO European Region, 31 of which are part of the European Union/European Economic Area, invested considerably in pandemic preparedness. This came in the wake of global threats posed by (re-)emerging diseases such as avian influenza A(H5N1) and...

During the past decade, the 53 Member States of the WHO European Region, 31 of which are part of the European Union/European Economic Area, invested considerably in pandemic preparedness. This came in the wake of global threats posed by (re-)emerging diseases such as avian influenza A(H5N1) and...